Continuous flow has been an integral part of development and production within the chemical industry for over a century, but has only recently gained traction in pharmaceutical manufacture. The recent interest is due to such factors as the exploration of extreme process conditions to improve throughput and quality, enhancing process safety through improved control and lower cost production of low volume compounds.
Part 1 of this webinar series took place in April 2018 and covered a brief history of continuous flow at Cambrex, the obstacles to be solved and overcome when implementing continuous flow and a brief look at the future. Since the last webinar, we are pleased to report that Cambrex was awarded a high commendation for our continuous flow activities at the CPhI Pharma Awards 2018.
This webinar will:
- Explore relevant examples of continuous flow in the manufacture of APIs and intermediates
- Illustrate examples of available technologies for continuous flow process development, focusing on practical applications and highlighting processing advantages
- Conclude with the use of PAT (Process Analytical Technologies) and integrated control strategies, including their role in commercialization and ultimate release strategies
Cambrex was awarded a high commendation at the CPhI Pharma Awards 2018 for the Continuous Flow Centre of Excellence within the Contract Services and Outsourcing category.
Shawn Conway, Director of Engineering R&D, Cambrex